GRDN
Get informed when a big investor buys or sells
+ FollowUndervalued by 40.1% based on the discounted cash flow analysis.
| Market cap | $2.50 Billion |
|---|---|
| Enterprise Value | $2.41 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.79 |
| Beta | 0.1 |
| Outstanding Shares | 63,327,000 |
| P/E Ratio | 37.56 |
|---|---|
| PEG | 26.41 |
| Price to Sales | 1.71 |
| Price to Book Ratio | 9.86 |
| Enterprise Value to Revenue | 1.65 |
| Enterprise Value to EBIT | 21.85 |
| Enterprise Value to Net Income | 36 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.03 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 3.5392▲ 353.92% |
|---|---|
| Total Calls | 10,200▲ Infinity% |
| Total Puts | 36,100▲ 446.97% |
Holdings and activity of institutional investors.
| Ownership % | 46.72%▲ 2.00% |
|---|---|
| Total Invested | $1.24B▲ 16.13% |
| Investors Holding | 195▲ 23.00% |
No data
Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug ...